Yuanjun Ma

558 total citations
14 papers, 414 citations indexed

About

Yuanjun Ma is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuanjun Ma has authored 14 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Yuanjun Ma's work include Prostate Cancer Treatment and Research (6 papers), Neuroendocrine Tumor Research Advances (2 papers) and Temporomandibular Joint Disorders (2 papers). Yuanjun Ma is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Neuroendocrine Tumor Research Advances (2 papers) and Temporomandibular Joint Disorders (2 papers). Yuanjun Ma collaborates with scholars based in Sweden, United States and China. Yuanjun Ma's co-authors include Bo Xu, Xiaolei Ye, Hanqing Lin, Charlie Degui Chen, Yi Yu, Gang Han, Yang Xiang, Ziqi Zhu, Nele Brusselaers and Sten Nilsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and British Journal of Cancer.

In The Last Decade

Yuanjun Ma

12 papers receiving 409 citations

Peers

Yuanjun Ma
Dibash Kumar Das United States
Xinchao Pan United States
Binita Chakraborty United States
Yuanjun Ma
Citations per year, relative to Yuanjun Ma Yuanjun Ma (= 1×) peers Augusto Nogueira

Countries citing papers authored by Yuanjun Ma

Since Specialization
Citations

This map shows the geographic impact of Yuanjun Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanjun Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanjun Ma more than expected).

Fields of papers citing papers by Yuanjun Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanjun Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanjun Ma. The network helps show where Yuanjun Ma may publish in the future.

Co-authorship network of co-authors of Yuanjun Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanjun Ma. A scholar is included among the top collaborators of Yuanjun Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanjun Ma. Yuanjun Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
3.
He, Feng, Hongyun Zhang, Yuanjun Ma, et al.. (2024). Syndecan‐4 inhibition attenuates cartilage degeneration in temporomandibular joint osteoarthritis. Journal of Oral Rehabilitation. 51(11). 2324–2335. 3 indexed citations
4.
Abildgaard, Niels, Pekka Anttila, Anders Waage, et al.. (2024). Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries. European Journal of Cancer. 201. 113921–113921. 1 indexed citations
5.
Ma, Yuanjun, Feng He, Xiaohua Chen, et al.. (2023). Low‐frequency pulsed electromagnetic fields alleviate the condylar cartilage degeneration and synovitis at the early stage of temporomandibular joint osteoarthritis. Journal of Oral Rehabilitation. 51(4). 666–676. 3 indexed citations
6.
Abildgaard, Niels, Pekka Anttila, Yuanjun Ma, et al.. (2023). Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma. Clinical Epidemiology. Volume 15. 987–999. 3 indexed citations
7.
Giacobini, MaiBritt, Ewa Ahnemark, Emma Medin, et al.. (2023). Epidemiology, Treatment Patterns, Comorbidities, and Concomitant Medication in Patients with ADHD in Sweden: A Registry-Based Study (2018–2021). Journal of Attention Disorders. 27(12). 1309–1321. 10 indexed citations
8.
Valachis, Antonis, et al.. (2022). Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study. British Journal of Cancer. 127(4). 720–725. 25 indexed citations
9.
Doelen, Maarten J. van der, Yuanjun Ma, Niven Mehra, et al.. (2021). Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223. European Journal of Nuclear Medicine and Molecular Imaging. 48(10). 3325–3334. 17 indexed citations
10.
Shen, Qing, Yuanjun Ma, Anna Jöud, et al.. (2020). Psychiatric Disorders and Cardiovascular Diseases During the Diagnostic Workup of Suspected Prostate Cancer. JNCI Cancer Spectrum. 5(1). 5 indexed citations
11.
Ma, Yuanjun & Nele Brusselaers. (2017). Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk. Prostate Cancer and Prostatic Diseases. 21(1). 147–152. 21 indexed citations
13.
Ma, Yuanjun, Yali Miao, Johanna Sandgren, et al.. (2016). Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel resistant prostate cancer cells. SpringerPlus. 5(1). 1861–1861. 16 indexed citations
14.
Xiang, Yang, Ziqi Zhu, Gang Han, et al.. (2007). JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proceedings of the National Academy of Sciences. 104(49). 19226–19231. 308 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026